Literature DB >> 20153076

Interaction between cytokines, cannabinoids and the nervous system.

Lucie Jean-Gilles1, Bruno Gran, Cris S Constantinescu.   

Abstract

Cytokines play important roles in neuroinflammation and neurodegeneration. The endocannabinoid system (ES) is comprised of the CB1 and CB2 cannabinoid receptors, endogenous ligands, and proteins involved in endocannabinoid synthesis and inactivation. The ES participates in the regulation of immune responses in the nervous system. Activation of the cannabinoid system is associated with therapeutic effects that may be mediated by the down-regulation of cytokine expression. Here we review the findings from studies on the reciprocal regulation of the immune and cannabinoid systems, which is based on functional as well as anatomical connections. We then discuss mechanisms involved in the reciprocal regulation of cytokines and the ES. 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153076     DOI: 10.1016/j.imbio.2009.12.006

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  24 in total

Review 1.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

2.  Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model.

Authors:  Ivana Hradilová Svízenská; Václav Brázda; Ilona Klusáková; Petr Dubový
Journal:  J Histochem Cytochem       Date:  2013-05-08       Impact factor: 2.479

Review 3.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

4.  The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia.

Authors:  K S Lee; J Asgar; Y Zhang; M-K Chung; J Y Ro
Journal:  Neuroscience       Date:  2013-09-17       Impact factor: 3.590

5.  Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.

Authors:  Silvia Zoppi; Beatriz G Pérez Nievas; José L M Madrigal; Jorge Manzanares; Juan C Leza; Borja García-Bueno
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

6.  Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Authors:  Dario Siniscalco; Anna Sapone; Catia Giordano; Alessandra Cirillo; Laura de Magistris; Francesco Rossi; Alessio Fasano; James Jeffrey Bradstreet; Sabatino Maione; Nicola Antonucci
Journal:  J Autism Dev Disord       Date:  2013-11

7.  Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.

Authors:  S Zoppi; J L Madrigal; J R Caso; M S García-Gutiérrez; J Manzanares; J C Leza; B García-Bueno
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.

Authors:  D M Kerr; B Harhen; B N Okine; L J Egan; D P Finn; M Roche
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Interleukin-22 protects rat PC12 pheochromocytoma cells from serum deprivation-induced cell death.

Authors:  Yongchun Liu; Wenyan Pan; Shengmei Yang; Xiaoying Wu; Jianfu Wu; Jun Ma; Zengqiang Yuan; Songshu Meng
Journal:  Mol Cell Biochem       Date:  2012-09-16       Impact factor: 3.396

10.  Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients.

Authors:  A J Sánchez López; L Román-Vega; E Ramil Tojeiro; A Giuffrida; A García-Merino
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.